| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,113,000 | 2,037,000 | 1,990,000 | 1,966,000 | | Cost of Revenue | 1,601,000 | 1,544,000 | 1,531,000 | 1,641,000 | | | Gross Profit | 512,000 | 493,000 | 459,000 | 325,000 | | | Operating Expenses | | Research Development | 96,000 |
-
|
-
|
-
| | Selling General and Administrative | 321,000 | 341,000 | 335,000 | 344,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 133,000 | 152,000 | 124,000 | (19,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (157,000) | 11,000 | (8,000) | (78,000) | | Earnings Before Interest And Taxes | (24,000) | 163,000 | 104,000 | (85,000) | | Interest Expense | (153,000) | 71,000 | 47,000 | 35,000 | | Income Before Tax | 129,000 | 92,000 | 57,000 | (120,000) | | Income Tax Expense | 31,000 | 41,000 | 9,000 | (1,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 98,000 | 51,000 | 48,000 | (119,000) | | | Non-recurring Events | | Discontinued Operations | (5,000) | (2,000) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 93,000 | 49,000 | 48,000 | (119,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $93,000 | $49,000 | $48,000 | ($119,000) |
|
1.52% Nasdaq 
Income Statement
